KRYS - Krystal Biotech - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KRYS is currently covered by 9 analysts with an average price target of $213.53. This is a potential upside of $35.4 (19.87%) from yesterday's end of day stock price of $178.13.

Krystal Biotech's activity chart (see below) currently has 59 price targets and 76 ratings on display. The stock rating distribution of KRYS is 92.11% BUY and 7.89% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 84.92% with an average time for these price targets to be met of 287.33 days.

Highest price target for KRYS is $221, Lowest price target is $215, average price target is $187.67.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 28-Feb-2025. First documented stock forecast 28-Jun-2018.

Currently out of the existing stock ratings of KRYS, 35 are a BUY (92.11%), 3 are a HOLD (7.89%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$221

$37.08 (20.16%)

$221

1 months 6 days ago
(28-Feb-2025)

24/31 (77.42%)

$41.35 (23.02%)

210

Buy

$218

$34.08 (18.53%)

$212

1 months 14 days ago
(20-Feb-2025)

7/10 (70%)

$61.31 (39.13%)

409

Buy

$215

$31.08 (16.90%)

1 months 14 days ago
(20-Feb-2025)

4/5 (80%)

$58.31 (37.21%)

139

Hold

$215

$31.08 (16.90%)

$206

1 months 14 days ago
(20-Feb-2025)

1/4 (25%)

$58.31 (37.21%)

135

Buy

$220

$36.08 (19.62%)

$145

6 months 23 days ago
(11-Sep-2024)

2/3 (66.67%)

$21.21 (10.67%)

156

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KRYS (Krystal Biotech) average time for price targets to be met?

On average it took 287.33 days on average for the stock forecasts to be realized with a an average price target met ratio 84.92

Which analyst has the current highest performing score on KRYS (Krystal Biotech) with a proven track record?

JOSH SCHIMMER

Which analyst has the most public recommendations on KRYS (Krystal Biotech)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 2 ratings on KRYS

Which analyst is the currently most bullish on KRYS (Krystal Biotech)?

Joseph Pantginis with highest potential upside - $37.08

Which analyst is the currently most reserved on KRYS (Krystal Biotech)?

Wangzhi Li with lowest potential downside - -$66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?